Getting an ovarian cancer diagnosis changes everything. The plan usually starts with a scalpel. Surgeons remove the ovaries, the fallopian tubes, and often the uterus. This procedure is called a hysterectomy with bilateral salpingo-oophorectomy. It’s a big step. But surgery is rarely the only move in the deck.
Doctors often pair it with chemotherapy. These drugs travel through your blood to hunt down cancer cells that might have slipped away during the operation. Radiation therapy sometimes joins the fight too, though it is less common for this specific cancer than for others.
Then there are the newer tools. Targeted therapy uses drugs designed to block specific molecules that help cancer grow. It’s not a blanket attack. It’s more like a precision strike on the biological machinery fueling the tumor. Hormone therapy is another option. For some types of ovarian cancer, estrogen and other hormones act like fuel. Drugs like tamoxifen or aromatase inhibitors work to block these signals. They starve the cancer rather than blasting it with poison.
Why does this matter? Because ovarian cancer isn’t just one disease. It’s a group of similar conditions. The treatment depends on the subtype. Some tumors respond well to hormone blockers. Others need aggressive chemo. And some might benefit most from the targeted approach.
Surgery remains the cornerstone. You can’t remove a tumor without cutting it out first. But after the incision closes, the real work begins. Chemo and targeted drugs manage what was left behind. They keep the disease in check. For some patients, this combination leads to long-term remission. For others, the cancer returns.
It’s a complex landscape. Not every patient gets the same treatment. Genetics play a role. Stage of the disease matters. Your overall health dictates what your body can handle. But the core elements stay the same. Cut it out. Wash it out. Stop it from coming back.
